Table 3.

Inhibition of Platelet Reactivity

	Ticagrelor+Eptifibatide Bolus (n=33) Group 1 (%)	Ticagrelor+Eptifibatide Bolus and Infusion (n=33) Group 2 (%)	P Value
%IPA (ADP 20 μmol/L)
2 h	99.59±0.43	99.88±1.0	0.18
6 h	98.4±4.4	99.31±2.9	0.40
24 h	55.7±23	59.4±27	0.45
%IPA (ADP 5 μmol/L)
2 h	99.9±0.90	99.9±0.25	0.98
6 h	99.1±2.4	99.5±1.9	0.84
24 h	66.27±17.6	68.4±22.3	0.74
%IPA (TRAP 20 μmol/L)
2 h	88.9±8.1	92±5.5	0.10
6 h	74. 4±17.5	87.4±13.5	0.004
24 h	21.12±19.5	27.8±34.2	0.78
%IPA (TRAP 10 μmol/L)
2 h	96.6±4.9	97.5±4.6	0.53
6 h	86.4±16.4	93.9±9.7	0.071
24 h	35±27	32±44	0.074
%IPA (collagen 2 μmol/L per μL)
2 h	99.7±0.72	99.6±0.96	0.60
6 h	97.5±7.9	98.5±4.2	0.60
24 h	61.6±44	68±45	0.60

IPA indicates inhibition of platelet reactivity; TRAP, thrombin receptor‐activating peptide.